News and Insight
In the race to make vaccines faster, cheaper, and more equitably distributed, one challenge has quietly dragged behind the spotlight: upstream bioprocess …
Cell-to-cell adhesion of mammalian cells is what cells are supposed to do, but can be quite detrimental to bioprocessing, upstream and downstream, …
CellRev launches its proprietary media additive AggreGuard™ which prevents aggregation of adherent cells and increases cell yield in existing VERO processes CellRev, …
Continuous processing is not new and is being adopted by more and more industries as they acknowledge the inherent limitations of batch …
CellRev has developed a revolutionary new approach to adherent cell culture, promising to transform the commercial potential of this nascent field. The …
Original post from Business Live The university spin-out has developed cell growth tech that offers an alternative to factory farming of animals …
Original post from Bionow Technology disrupter CellRev, previously known as CellulaRevolution, which aims to revolutionise cell cultivation has undergone a complete brand …
